During early development stages, we help you to:

• Develop early economic models to explore value propositions.
• Navigate uncertainty with structured and forward-looking evidence strategies tailored to your technology’s specific context.
• Understand the buying language of health systems and the type of economic evidence needed for early adoption stakeholders.
• Stay on top of the rapidly evolving assessment landscape for these technologies.

As your product develops, we provide support to:

• Address evidentiary challenges by identifying the appropriate methods for generating evidence for different types of digital technologies and clinical situations.
• Integrate patient- and clinician-reported outcomes to capture the full value of your technology in real-world settings.
• Structure your evidence plans to anticipate future health technology assessment (HTA) and payer requirements.
• Conduct gap analyses to identify gaps in existing evidence, prioritising the clinical and economic evidence required to demonstrate the value of your technology.
• Synthesise your evidence and value story through literature reviews, economic models and statistical analysis.

Preparing your value proposition and market access strategy is an important factor in a successful launch. We work with you to:

• Align your evidence with the expectations of payers, hospital procurement, and other key decision makers.
• Create compelling value communications that are easy to interpret and resonate with stakeholders.
• Anticipate payer expectations for economic models and evidence submissions, considering how to maintain a consistent value narrative through multiple product iterations.

After launch, continuous monitoring and evidence generation are important for long-term success. We assist you to:

• Strengthen your value proposition with real-world data that reflects the lived experiences of patients and clinicians.
• Address new evidentiary challenges that emerge in the real world.
• Prepare for evolving healthcare priorities by embedding considerations of sustainability and equity into any continuous evidence plans.
• Analyse patient registries and health databases to collect real-world data supporting your product.